Cargando…

Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease—A 10-Year Cohort Study

Chronic obstructive pulmonary disease (COPD) is an inflammatory condition with constantly increasing mortality rates. Interleukin (IL)-33 and its decoy receptor, soluble suppression of tumorigenicity 2 (sST2), play a central role in the inflammatory response during infection. sST2 was suggested as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urban, Matthias H., Stojkovic, Stefan, Demyanets, Svitlana, Hengstenberg, Christian, Valipour, Arschang, Wojta, Johann, Burghuber, Otto C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745630/ https://www.ncbi.nlm.nih.gov/pubmed/35011794 http://dx.doi.org/10.3390/jcm11010056

Ejemplares similares

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Soluble ST2 in Patients with Carotid Artery Stenosis—Association with Plaque Morphology and Long-Term Outcome
por: Stojkovic, Stefan, et al.
Publicado: (2023)

Soluble ST2 as a Potential Biomarker for Abdominal Aortic Aneurysms—A Single-Center Retrospective Cohort Study
por: Klopf, Johannes, et al.
Publicado: (2022)

GDF‐15 is a better complimentary marker for risk stratification of arrhythmic death in non‐ischaemic, dilated cardiomyopathy than soluble ST2
por: Stojkovic, Stefan, et al.
Publicado: (2018)

The Paradigm Change of IL-33 in Vascular Biology
por: Demyanets, Svitlana, et al.
Publicado: (2021)

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy
por: Kieler, Markus, et al.
Publicado: (2018)

Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD
por: Urban, Matthias Helmut, et al.
Publicado: (2017)

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease phenotypes: imprint on pharmacological and non-pharmacological therapy
por: Bakeer, Mostafa, et al.
Publicado: (2020)

Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue
por: Pentz, Richard, et al.
Publicado: (2018)

Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
por: Demyanets, Svitlana, et al.
Publicado: (2013)

Swiss Experience in Therapy With Dual Bronchodilation in Chronic Obstructive Pulmonary Disease in Relation to Self-Reported Physical Functionality
por: Spielmanns, Marc, et al.
Publicado: (2021)

Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery
por: Rega-Kaun, Gersina, et al.
Publicado: (2019)

Soluble neprilysin and survival in critically ill patients
por: Lenz, Max, et al.
Publicado: (2022)

Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesicles
por: Hohensinner, Philipp J., et al.
Publicado: (2020)

PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD
por: Koblizek, Vladimir, et al.
Publicado: (2023)

Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review
por: Huf, Waltraud Elisabeth, et al.
Publicado: (2023)

Modern Bronchoscopic Treatment Options for Patients with Chronic Bronchitis
por: Mayr, Anna Katharina, et al.
Publicado: (2023)

“Nitrogen Wash-Out” in Non-Hypoxaemic Patients with Spontaneous Pneumothorax: A Narrative Review
por: Grasmuk-Siegl, Erwin, et al.
Publicado: (2023)

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation
por: Stojkovic, Stefan, et al.
Publicado: (2016)

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)
por: Slebos, Dirk-Jan, et al.
Publicado: (2020)

Impaired Spontaneous Baroreceptor Reflex Sensitivity in Patients With COPD Compared to Healthy Controls: The Role of Lung Hyperinflation
por: Mayr, Anna Katharina, et al.
Publicado: (2022)

G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease
por: Katsaros, Katharina M., et al.
Publicado: (2015)

Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment
por: Eilenberg, W., et al.
Publicado: (2017)

Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes
por: Theofilatos, Konstantinos, et al.
Publicado: (2023)

Monocyte subsets predict mortality after cardiac arrest
por: Krychtiuk, Konstantin A., et al.
Publicado: (2020)

Atherosclerotic plaque detected by transesophageal echocardiography is an independent predictor for all-cause mortality
por: Heidari, Houtan, et al.
Publicado: (2020)

Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator
por: Hou, Zhi-wei, et al.
Publicado: (2020)

Assessment of Patient Experiences with Respimat(®) in Everyday Clinical Practice
por: Taube, Christian, et al.
Publicado: (2020)

Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment
por: Spielmanns, Marc, et al.
Publicado: (2022)

Association of soluble ST2 with all-cause and cardiovascular mortality in renal transplant recipients: a single-centre cohort study
por: Devine, Paul A., et al.
Publicado: (2020)

Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab
por: Totschnig, David, et al.
Publicado: (2022)

Soluble ST2 plasma concentrations predict mortality in severe sepsis
por: Hoogerwerf, Jacobien J., et al.
Publicado: (2010)

Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension
por: Sun, Yuanyuan, et al.
Publicado: (2021)

Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients
por: Choi, Yu Bum, et al.
Publicado: (2020)

Tobacco addiction and smoking cessation in Austrian migrants: a cross-sectional study
por: Urban, Matthias, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2jptli3hlemcq8chcgsgu3rgi9